Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-19-041176

President and CEO sold 18,333 shares at $20.76 ($380,593)

  • President and CEO gave 40,000 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2019-05-14 Gift −40,000 2,520,971 I
Watts Ryan J. President and CEO 2019-07-01 Sale −18,333 $20.76 $380,593 2,502,638 I
Open-market sales · 18,333 sh · avg $20.76 · $380,593
Loading xslF345X03/doc4.xml…